ReutersThe world is no better prepared for a new pandemic than it was when coronavirus emerged in 2019 and may actually be in a worse place given the economic toll, according to a panel set up by the World Health Organization (WHO) to evaluate the global response.
Vifor Pharma and Travere Therapeutics inked a collaboration and licensing partnership to commercialize sparsentan in Europe, Australia and New Zealand. The drug is being developed to treat FSGS and IgAN, which are rare progressive kidney diseases that are leading causes of end-stage kidney disease.
Covid-19 probably can be eradicated globally, just like polio, according to research just published in BMJ Global Health. That assumes, however, that a high rate of vaccination occurs globally and that there is a quick response to emerging variants.
Australia’s second most populous state Victoria entered a five-day lockdown on Feb. 13 as authorities raced to prevent a third wave of Covid-19 cases sparked by the highly infections UK variant.
Global coronavirus cases surpassed 100 million on Jan. 27, according to a Reuters tally, as countries around the world struggle with new virus variants and vaccine shortfalls.
The global tally of confirmed coronavirus cases hit 60 million on Nov. 25, with the pace of new infections accelerating and the United States reporting record numbers of hospitalizations, according to a Reuters tally.
The World Health Organization is setting up an independent panel to review the WHO’s handling of the COVID-19 pandemic and the response by governments worldwide.
Randall Bolten – longtime Silicon Valley CFO, UC Berkeley Professor and author of the book Painting with Numbers: Presenting Financials and Other Numbers So People Will Understand You – released a research note on updated COVID-19 testing numbers. Broken down by country through May 10, 2020, the United States is not near the top of the pack.
